DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
compose your message
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Study Confirms Safe Use of Opioids for Pain Control in Sickle Cell Disease
The most common cause of hospital admission among patients with sickle cell disease (SCD) are excruciating pain crises, for which opioid medications are a mainstay of treatment. There have been questions about whether the US opioid epidemic, which has resulted in large increases in opioid-related overdoses and deaths over the past 2 decades, may have affected the death rate among patients with SCD who were treated with opioids in the hospital to relieve pain crises.
According to a study results presented at the 60th American Society of Hematology Annual Meeting & Exposition in San Diego, California, on December 2, 2018, the use of opioid medications for pain control in SCD is relatively safe, and there has been no associated increase in hospital SCD mortality.
education & researchPain and opioid use after reversal of sickle cell disease following hematopoietic stem cell transplantPain is the most common symptom of sickl...
education & researchUse of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful V...Introduction: Recently, there has been g...
news & eventsOrphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
videos & visualsPatient Perspective: The Journey of Pain in Sickle Cell Diseasehttps://www.youtube.com/watch?v=F4raFO0e...
news & eventsHospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
videos & visuals2017 SiNERGe Webinar July 14 – Chronic Opioid Therapy & Sickle Cell Diseasehttps://www.youtube.com/watch?v=8WZNTwPD...
news & eventsSafety and early hints of benefit seen in phase 1b trial of PF-04447943Sickle cell disease (SCD) patients were ...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.